ENMD-2076

EntreMed commences ENMD-2076 Phase 2 trial
The Fly on the Wall
Thu, 10/31/13 - 11:16 am
ENMD-2076
EntreMed
ovarian cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
Wed, 07/25/12 - 09:33 am
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076
EntreMed shares spike on PhII cancer data
Fierce Biotech
Mon, 10/3/11 - 11:42 am
EntreMed
ENMD-2076
ovarian cancer
EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients
Yahoo/PR NewsWire
Sat, 06/4/11 - 09:57 am
EntreMed
ENMD-2076
ovarian cancer
Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
BioSante
LibiGel
testosterone
EntreMed
ENMD-2076
cancer
Protalix BioTherapeutics
UPLYSO
ovarian cancer
Vivus
Qnexa
obesity
EMD 640744
cancer vaccines
EntreMed Raises Additional $3 Million to Further Support Clinical Development of ENMD-2076 in Ovarian Cancer
Yahoo/PR NewsWire
Sat, 04/17/10 - 12:20 pm
EntreMed
ENMD-2076
Aurora A/angiogenic kinase inhibitor
ovarian cancer